Skip to content
value.today

AbbVie Inc. vs Eli Lilly and Company

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Eli Lilly and Company is the larger company by market value: $1.20 T against $514.0 B for AbbVie Inc., 2.3 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Oct 26, 2026 for Eli Lilly and Company).
  • Eli Lilly and Company had more revenue: $65.2 B against $61.2 B for AbbVie Inc., both in the year to December 2025.
  • Eli Lilly and Company earned more: net income of $20.6 B against $4.2 B for AbbVie Inc.
  • Eli Lilly and Company keeps more of each dollar of sales: a net margin of 31.7% against 6.9% for AbbVie Inc.
  • AbbVie Inc. employs more people: 57,000 against 50,000 at Eli Lilly and Company. Each employee brings in about $1,072,982 of revenue at AbbVie Inc. and $1,303,580 at Eli Lilly and Company.
  • On price to earnings, AbbVie Inc. trades at 49.7× and Eli Lilly and Company at 43.4×: investors pay more for each dollar of AbbVie Inc.'s profit.
  • Eli Lilly and Company's revenue grew faster in its latest fiscal year: +44.7% against +8.6% for AbbVie Inc.
  • On the Piotroski F-score, a nine-point test of improving finances, AbbVie Inc. scores 8 and Eli Lilly and Company 7.
  • Dividend yield: 2.27% for AbbVie Inc. and 0.45% for Eli Lilly and Company.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

02344677019352020202120222023202420252026AbbVie Inc. 390Eli Lilly and Company 935

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$16B$33B$49B$65B201720182019202020212022202320242025AbbVie Inc. $61BEli Lilly and Company $65B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAbbVie Inc.
ABBV · #26 in the world
Eli Lilly and Company
LLY · #13 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded20131876
Size
Market cap$514.0 B$1.20 T
Revenue$61.2 B$65.2 B
Net income$4.2 B$20.6 B▲ best
Employees57,00050,000
Valuation
P/E ratio49.7×43.4×
Price to sales7.8×13.9×
Price to book—45.1×
Free cash flow yield3.5%—
Profitability
Gross margin70.2%83.0%▲ best
Operating margin24.6%—
Net margin6.9%31.7%▲ best
Return on equity—101.2%
Return on invested capital16.0%—
Growth
Revenue growth8.6%44.7%▲ best
Revenue growth, 3 years a year1.8%31.7%▲ best
Earnings per share growth-1.3%96.0%▲ best
Financial strength
Debt to equity—1.5×
Interest cover5.2×—
Cash
Free cash flow margin29.1%—
Shareholder returns
Dividend yield2.3%▲ best0.5%
Shareholder yield2.5%▲ best0.8%
Strength scores
Piotroski F-score8 of 9▲ best7 of 9
Altman Z-score zonegrey—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, AbbVie Inc. or Eli Lilly and Company?

Eli Lilly and Company is the larger company by market value: $1.20 T against $514.0 B for AbbVie Inc., 2.3 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Oct 26, 2026 for Eli Lilly and Company).

Which makes more money, AbbVie Inc. or Eli Lilly and Company?

Eli Lilly and Company had more revenue: $65.2 B against $61.2 B for AbbVie Inc., both in the year to December 2025. Eli Lilly and Company earned more: net income of $20.6 B against $4.2 B for AbbVie Inc.

Which is more profitable, AbbVie Inc. or Eli Lilly and Company?

Eli Lilly and Company keeps more of each dollar of sales: a net margin of 31.7% against 6.9% for AbbVie Inc.

Which has more employees, AbbVie Inc. or Eli Lilly and Company?

AbbVie Inc. employs more people: 57,000 against 50,000 at Eli Lilly and Company. Each employee brings in about $1,072,982 of revenue at AbbVie Inc. and $1,303,580 at Eli Lilly and Company.

Is AbbVie Inc. cheaper than Eli Lilly and Company?

On price to earnings, AbbVie Inc. trades at 49.7× and Eli Lilly and Company at 43.4×: investors pay more for each dollar of AbbVie Inc.'s profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.

Which is growing faster, AbbVie Inc. or Eli Lilly and Company?

Eli Lilly and Company's revenue grew faster in its latest fiscal year: +44.7% against +8.6% for AbbVie Inc.

Which is financially stronger, AbbVie Inc. or Eli Lilly and Company?

On the Piotroski F-score, a nine-point test of improving finances, AbbVie Inc. scores 8 and Eli Lilly and Company 7.

Sources#

Every figure on this page comes from these, with the date shown next to it.